Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
4.350
+0.120 (2.84%)
At close: May 12, 2025, 4:00 PM
4.252
-0.098 (-2.26%)
After-hours: May 12, 2025, 7:40 PM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $387.77 million as of May 12, 2025. Its market cap has decreased by -29.52% in one year.
Market Cap
387.77M
Enterprise Value
-66.52M
1-Year Change
-29.52%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $387.77M, a decrease of -55.39%. That is a compound annual growth rate of -18.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 377.08M | -21.03% |
| Dec 31, 2024 | 477.50M | -57.41% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |